1. Home
  2. PHIO vs SNES Comparison

PHIO vs SNES Comparison

Compare PHIO & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIO
  • SNES
  • Stock Information
  • Founded
  • PHIO 2011
  • SNES 2004
  • Country
  • PHIO United States
  • SNES United States
  • Employees
  • PHIO N/A
  • SNES N/A
  • Industry
  • PHIO Biotechnology: Pharmaceutical Preparations
  • SNES Agricultural Chemicals
  • Sector
  • PHIO Health Care
  • SNES Industrials
  • Exchange
  • PHIO Nasdaq
  • SNES Nasdaq
  • Market Cap
  • PHIO 2.3M
  • SNES 2.3M
  • IPO Year
  • PHIO N/A
  • SNES 2016
  • Fundamental
  • Price
  • PHIO $2.61
  • SNES $3.16
  • Analyst Decision
  • PHIO Strong Buy
  • SNES Strong Buy
  • Analyst Count
  • PHIO 1
  • SNES 1
  • Target Price
  • PHIO $36.00
  • SNES $10.00
  • AVG Volume (30 Days)
  • PHIO 30.8K
  • SNES 311.7K
  • Earning Date
  • PHIO 11-14-2024
  • SNES 11-12-2024
  • Dividend Yield
  • PHIO N/A
  • SNES N/A
  • EPS Growth
  • PHIO N/A
  • SNES N/A
  • EPS
  • PHIO N/A
  • SNES N/A
  • Revenue
  • PHIO N/A
  • SNES $1,651,000.00
  • Revenue This Year
  • PHIO N/A
  • SNES $91.45
  • Revenue Next Year
  • PHIO N/A
  • SNES $101.31
  • P/E Ratio
  • PHIO N/A
  • SNES N/A
  • Revenue Growth
  • PHIO N/A
  • SNES 38.16
  • 52 Week Low
  • PHIO $2.17
  • SNES $1.90
  • 52 Week High
  • PHIO $10.35
  • SNES $21.40
  • Technical
  • Relative Strength Index (RSI)
  • PHIO 48.74
  • SNES 56.47
  • Support Level
  • PHIO $2.58
  • SNES $2.32
  • Resistance Level
  • PHIO $2.91
  • SNES $5.00
  • Average True Range (ATR)
  • PHIO 0.21
  • SNES 0.52
  • MACD
  • PHIO 0.01
  • SNES 0.13
  • Stochastic Oscillator
  • PHIO 26.76
  • SNES 35.66

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Share on Social Networks: